Format

Send to

Choose Destination
Bioorg Med Chem. 2013 Aug 15;21(16):4846-51. doi: 10.1016/j.bmc.2013.04.020. Epub 2013 Apr 18.

Validation of inhibitors of an ABC transporter required to transport lipopolysaccharide to the cell surface in Escherichia coli.

Author information

1
Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford Str., Cambridge, MA 02138, United States. dsherman@fas.harvard.edu

Abstract

The presence of lipopolysaccharide (LPS) in the outer leaflet of the outer membrane (OM) of Gram-negative bacteria creates a permeability barrier that prevents the entry of most currently available antibiotics. The seven lipopolysaccharide transport (Lpt) proteins involved in transporting and assembling this glycolipid are essential for growth and division in Escherichia coli; therefore, inhibiting their functions leads to cell death. LptB, the ATPase that provides energy for LPS transport and assembly, forms a complex with three other inner membrane (IM) components, LptC, F, and G. We demonstrate that inhibitors of pure LptB can also inhibit the full IM complex, LptBFGC, purified in detergent. We also compare inhibition of LptB and the LptBFGC complex with the antibiotic activity of these compounds. Our long-term goal is to develop tools to study inhibitors of LPS biogenesis that could serve as potentiators by disrupting the OM permeability barrier, facilitating entry of clinically used antibiotics not normally used to treat Gram-negative infections, or that can serve as antibiotics themselves.

KEYWORDS:

ABC transporter; Antibiotics; Gram-negative; Lipopolysaccharide

PMID:
23665139
PMCID:
PMC3821166
DOI:
10.1016/j.bmc.2013.04.020
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center